Age-dependent ECoG spectrum power alterations are reduced by phosphatidylserine in rats.

Neuropharmacology

Institute of Pharmacology, Faculty of Medicine and Surgery, University of Reggio Calabria, Catanzaro, Italy.

Published: September 1989

The present experiments were carried out in order to characterize the changes in ECoG spectrum power occurring in old compared with young rats. In addition, it was planned to ascertain whether chronic treatment with phosphatidylserine affected possible ECoG changes occurring in aged animals. In comparison to 3 months-old rats, the ECoG activity of 13-15 months-old rats showed spontaneous single or bursts of monophasic and biphasic spikes. In addition, spectrum analysis revealed a significant increase in the power of the lowest frequency band (0.25-3 Hz), accompanied by a decrease in 6-9, 9-12 and 12-16 Hz power. Chronic oral or parenteral treatment with phosphatidylserine gradually reversed the changes in ECoG spectrum power occurring in old rats and produced, at the ECoG level, a distribution pattern of single frequency, bands similar to that observed in young animals.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0028-3908(89)90200-1DOI Listing

Publication Analysis

Top Keywords

ecog spectrum
12
spectrum power
12
changes ecog
8
power occurring
8
treatment phosphatidylserine
8
months-old rats
8
power
5
rats
5
ecog
5
age-dependent ecog
4

Similar Publications

Spatial and spectral changes in cortical surface potentials during pinching versusthumb and index finger flexion.

Neurosci Lett

January 2025

Department of Neurologic Surgery, Mayo Clinic, Rochester, MN, USA; Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, USA.

Electrocorticographic (ECoG) signals provide high-fidelity representations of sensorimotor cortex activation during contralateral hand movements. Understanding the relationship between independent and coordinated finger movements along with their corresponding ECoG signals is crucial for precise brain mapping and neural prosthetic development. We analyzed subdural ECoG signals from three adult epilepsy patients with subdural electrode arrays implanted for seizure foci identification.

View Article and Find Full Text PDF

Characterising the power spectrum dynamics of the non-REM to REM sleep transition.

J Sleep Res

November 2024

Departamento de Fisiología, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay.

The transition from non-rapid eye movement (NREM) to rapid eye movement (REM) sleep is considered a transitional or intermediate stage (IS), characterised by high amplitude spindles in the frontal cortex and theta activity in the occipital cortex. Early reports in rats showed an IS lasting from 1 to 5 s, but recent studies suggested a longer duration of this stage of up to 20 s. To further characterise the IS, we analysed its spectral characteristics on electrocorticogram (ECoG) recordings of the olfactory bulb (OB), primary motor (M1), primary somatosensory (S1), and secondary visual cortex (V2) in 12 Wistar male adult rats.

View Article and Find Full Text PDF

Background: While immune checkpoint inhibitors (ICIs) are increasingly reshaping the therapeutic landscape of non-small-cell lung cancer (NSCLC), only a limited proportion of patients achieve a relevant and long-lasting benefit with these treatments, calling for the identification of clinical and, ideally modifiable, predictors of efficacy. Body composition phenotypes may reflect aspects of patients' immunology and thereby their ability to respond to ICIs. This study aims to explore the possible association between pre-treatment body composition phenotypes, tumour response, and clinical outcomes in patients receiving first-line pembrolizumab monotherapy for advanced NSCLC.

View Article and Find Full Text PDF
Article Synopsis
  • Concurrent chemoradiation is the standard treatment for unresectable locally advanced head and neck cancer, but it can lead to both acute side effects (like skin and throat issues) and long-term effects that can persist for years.
  • A study conducted at Christian Medical College analyzed the late-effects from radiation therapy in patients with head and neck cancer, revealing that salivary gland toxicity was the most prevalent, leading to problems such as dysphagia and dental caries.
  • Advances in radiation technology have improved patient outcomes, but there's still a need to carefully manage radiation exposure to normal tissues to minimize adverse effects on quality of life.
View Article and Find Full Text PDF
Article Synopsis
  • Dual immune checkpoint blockade (ICB) using CTLA4 and PD-(L)1 inhibitors shows improved anti-tumor effectiveness and immune toxicity compared to PD-(L)1 inhibitors alone in advanced non-small-cell lung cancer (NSCLC) patients.
  • Patients with mutations in STK11 and/or KEAP1 genes benefit more from the combination treatment compared to those receiving only PD-(L)1 inhibitors, as shown in the POSEIDON trial.
  • The loss of KEAP1 serves as a strong predictor for the success of dual ICB, as it leads to a more favorable outcome by changing the tumor's immune environment to better engage CD4 and CD8 T cells for anti-tumor activity. *
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!